Connect

Innovate

Transform

Global Think-Tank on Steatotic Liver Disease

  • 5-6 June 2025

  • Palau Macaya | Barcelona, Spain

Join the leading think-tank on SLD, where we connect healthcare professionals, patient advocates, and industry to exchange best practices in the prevention, diagnosis, treatment, and management of MASLD/MASH. Through innovative, actionable strategies, we’re driving transformative efforts to end MASLD/MASH as a public health threat by 2030.

About the Think-tank

This 2-day flagship event* of the think-tank consists of five main sessions and three roundtable discussions, with key topics focused on steatotic liver disease prevention, diagnosis, treatment, management and public health and policies.

Expert panels will present evidence-based case studies showcasing the latest advances in non-invasive diagnostics. Leading hepatologists, endocrinologists, primary care physicians, nurses, and nutritionists will contribute to building a community of practice by exploring collaborative and integrated approaches for managing MASLD/MASH.

Discussions will also address key topics such as patient engagement, health literacy, and raising broader awareness within healthcare systems and among the public. Particular attention will be given to the inclusion of MASLD/MASH in clinical guidelines and screening policies, as well as tackling health inequities and disparities where they arise.

*Attendance is limited. All applications for registration are reviewed, and will be notified of invitation status and fee via email within one week.

Prevention

Diagnosis

Treatment

Management

Public health & policy

Think-tank leadership

Jeffrey V Lazarus – Director

Professor, CUNY Graduate School of Public Health and Health Policy, NY, USA. Research Professor, Barcelona Institute for Global Health (ISGlobal), Spain. Director, MASH Cities.

Jörn M Schattenberg – Co-director

Professor, Director. Department of Internal Medicine. Saarland University Medical Centre, Germany.

Naim Alkhouri – Co-director

Chief Medical Officer. Chief of Translant Hepatology. Director of the Fatty Liver Programme at Arizona Liver Health, USA.

Dídac Mauricio – Local Chair

Department of Endocrinology & Nutrition. CIBERDEM, Hospital de la Santa Creu i Sant Pau, Spain. Professor, University of Vic. Central University of Catalonia, Vic, Spain.

Maja Thiele – Scientific Committee Chair

Professor of Hepatology, Department of Gastroenterology and Hepatology, Odense University Hospital and University of Southern Denmark, Denmark.

Organising committee

  • Kenneth Cusi, Professor of Medicine at the Division of Endocrinology, Diabetes & Metabolism, University of Florida, USA.
  • Maru Rinella, Gastroenterologist, Director, Metabolic and Fatty Liver Disease Dept, University of Chicago, USA.
  • Emmanuel Tsochatzis, Hepatologist, Royal Free Hospital, UK.
  • Shira Zelber-Sagi, University of Haifa, The Tel-Aviv Medical Center, Israel.

Scientific committee

  • Alina Allen, Mayo Clinic Rochester, USA.
  • Meena Bansal, Division of Liver Diseases, Icahn School of Medicine at Mount Sinai, USA.
  • Paul Brennan, University of Dundee, Scotland, UK.
  • Cyrielle Caussy, Lyon University, Lyon South Hospital, France.
  • Nikos Dedes, Patient advocate, Greece.
  • Ajay Duseja, Professor & Head of Dep. of Hepatology, Post Grad Institute of Medical Education & Research, Chandigarh, India .
  • Hannes Hagström, Department of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden.
  • Scott Isaacs, Endocrinologist, Emory University School of Medicine, USA.
  • Manuel Romero-Gómez, Virgen del Rocío University Hospital, University of Seville, Spain.
  • Wendy Spearman, University of Cape Town, South Africa.
  • Maja Thiele, Professor of Hepatology, Odense University Hospital, University of Southern Denmark, Denmark.
  • Vincent Wong, The Chinese University of Hong Kong.
  • Yusuf Yilmaz, Marmara University, Turkey.

The Venue

Located in the heart of Barcelona, close to the Sagrada Familia, Palau Macaya is located within Casa Macaya.

An architectural gem of Catalan art nouveau, Casa Macaya was commissioned in 1898 by Romà Macaya i Gibert to architect Josep Puig i Cadafalch, with construction completed in 1901, shortly after Casa Amatller.

In 1976, thanks to the initiative of the Historical Archive of the College of Architects of Catalonia, Casa Macaya was classified as a cultural asset of national interest and a historical monument. In 1979, it was also included in the Catalog of Architectural, Historical, and Artistic Heritage of the City of Barcelona.

Become a sponsor

Interested in becoming a sponsor of the event?

Showcase your business to a diverse audience, including hepatologists, endocrinologists, primary care physicians, researchers, the patient community, and representatives from the private sector.

As a sponsor, you’ll get unique visibility through strategic logo placements, exhibition space, social media exposure, networking opportunities, and more. Contact our sponsorship team to find out more about the various sponsorship packages available.

Contact sponsorship team

Sponsors

Platinum

Gold

Silver

Bronze

Friends

Additional inquiries

Would you like to collaborate or partner with us? Do you have any questions?

Feel free to reach out!

Terms and conditions*